NASDAQ:AFIB Acutus Medical - AFIB Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Acutus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $1.87 +0.21 (+12.65%) (As of 02/1/2023 12:00 AM ET) Add Compare Share Share Today's Range$1.66▼$1.9450-Day Range$0.68▼$1.8752-Week Range$0.48▼$2.49Volume339,041 shsAverage Volume245,269 shsMarket Capitalization$53.21 millionP/E RatioN/ADividend YieldN/APrice Target$2.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Acutus Medical MarketRank™ ForecastAnalyst RatingHold2.33 Rating ScoreUpside/Downside7.0% Upside$2.00 Price TargetShort InterestHealthy1.61% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.16Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($2.84) to ($2.77) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.73 out of 5 starsMedical Sector558th out of 1,053 stocksSurgical & Medical Instruments Industry57th out of 105 stocks 1.2 Analyst's Opinion Consensus RatingAcutus Medical has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $2.00, Acutus Medical has a forecasted upside of 7.0% from its current price of $1.87.Amount of Analyst CoverageAcutus Medical has received no research coverage in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.61% of the float of Acutus Medical has been sold short.Short Interest Ratio / Days to CoverAcutus Medical has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Acutus Medical has recently decreased by 65.83%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldAcutus Medical does not currently pay a dividend.Dividend GrowthAcutus Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AFIB. Previous Next 2.9 News and Social Media Coverage News SentimentAcutus Medical has a news sentiment score of 0.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.73 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Acutus Medical this week, compared to 1 article on an average week.Search Interest2 people have searched for AFIB on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows1 people have added Acutus Medical to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Acutus Medical insiders have not sold or bought any company stock.Percentage Held by Insiders24.30% of the stock of Acutus Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 36.32% of the stock of Acutus Medical is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Acutus Medical are expected to grow in the coming year, from ($2.84) to ($2.77) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Acutus Medical is -0.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Acutus Medical is -0.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAcutus Medical has a P/B Ratio of 0.49. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Acutus Medical (NASDAQ:AFIB) StockAcutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.Read More Receive AFIB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Acutus Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address AFIB Stock News HeadlinesJanuary 31, 2023 | benzinga.comGlobal Electrophysiology Devices Market Is Expected To Increase to US$ 20.80 Billion by 2033-End: Fact.MR AnalysisJanuary 18, 2023 | seekingalpha.comAcutus Medical Focuses On Existing Customer Base As Revenue Growth FaltersFebruary 2, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.January 9, 2023 | markets.businessinsider.comAcutus Medical Sees Q4, FY22 Revenues Well Above Estimates; Appoints Takeo Mukai As CFOJanuary 9, 2023 | finance.yahoo.comAcutus Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Results and Appointment of Chief Financial OfficerDecember 29, 2022 | finance.yahoo.comAcutus Medical Announces Acceptance of the AcQForce Flutter Abstract for Presentation during the Late-Breaking Clinical Trials and First Report Investigations sessions at the 2023 AF SymposiumDecember 21, 2022 | benzinga.comLooking Into Acutus Medical's Return On Capital EmployedDecember 21, 2022 | finance.yahoo.comAcutus Medical Achieves EU MDR Submission Milestone in Sale of Left-Heart Access Portfolio to MedtronicFebruary 2, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.December 19, 2022 | finance.yahoo.comAcutus Medical Announces Full Market Release of next generation software platform AcQMap 8.5December 6, 2022 | finance.yahoo.comAcutus Medical Obtains MDR CE Mark of the AcQMap 3D Imaging and Mapping CatheterNovember 12, 2022 | finance.yahoo.comAcutus Medical Third Quarter 2022 Earnings: EPS Beats ExpectationsNovember 10, 2022 | markets.businessinsider.comBTIG Keeps Their Buy Rating on Acutus Medical (AFIB)November 10, 2022 | msn.comAcutus Medical, Inc. (AFIB) Reports Q3 Loss, Tops Revenue EstimatesNovember 10, 2022 | finance.yahoo.comAcutus Medical Reports Third Quarter 2022 Financial ResultsNovember 9, 2022 | msn.comEarnings Preview For Acutus MedicalNovember 3, 2022 | finance.yahoo.comAcutus Medical Achieves OEM Qualification Milestone in Sale of Left-Heart Access Portfolio to MedtronicOctober 27, 2022 | finance.yahoo.comAcutus Medical to Announce Third Quarter 2022 Financial ResultsOctober 20, 2022 | msn.comUsing marijuana, other drugs may trigger atrial fibrillationOctober 19, 2022 | msn.comAblation to treat atrial fibrillation may be riskier for womenOctober 19, 2022 | msn.comCommon A-Fib Treatment May Be Riskier for WomenOctober 18, 2022 | finance.yahoo.comAcutus Medical Announces Submission of Premarket Approval Application for AcQBlate Force Sensing Ablation Catheter & SystemOctober 4, 2022 | usatoday.comCardinals J.J. Watt treated for atrial fibrillation. What is Afib?October 2, 2022 | finance.yahoo.comA Acutus Medical, Inc. (NASDAQ:AFIB) insider increased their holdings by 153% last yearSeptember 28, 2022 | marketwatch.comAtrial Fibrillation Surgery Market to show impressive growth of 17.05% CAGR during the period 2022-2027 | 113 Report PagesSeptember 28, 2022 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and Acutus Medical (AFIB)September 17, 2022 | seekingalpha.comAFIB Acutus Medical, Inc.See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive AFIB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Acutus Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address AFIB Company Calendar Last Earnings11/10/2022Today2/02/2023Next Earnings (Estimated)3/29/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AFIB CUSIPN/A CIK1522860 Webwww.acutusmedical.com Phone442-232-6080Fax442-232-6081Employees291Year FoundedN/APrice Target and Rating Average Stock Price Forecast$2.00 High Stock Price Forecast$2.50 Low Stock Price Forecast$1.50 Forecasted Upside/Downside+7.0%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($3.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-117,680,000.00 Net Margins-545.51% Pretax Margin-545.51% Return on Equity-100.62% Return on Assets-56.07% Debt Debt-to-Equity Ratio0.59 Current Ratio5.12 Quick Ratio4.33 Sales & Book Value Annual Sales$15.76 million Price / Sales3.38 Cash FlowN/A Price / Cash FlowN/A Book Value$3.78 per share Price / Book0.49Miscellaneous Outstanding Shares28,452,000Free Float21,538,000Market Cap$53.21 million OptionableNot Optionable Beta0.65 Key ExecutivesMr. R. Scott Huennekens CPA (Age 58)M.B.A., Exec. Chairman Comp: $121kMr. David Harrison Roman (Age 40)CEO, Pres & Director Comp: $679.4kMr. Vincent J. Burgess (Age 57)Consultant Comp: $583.5kMr. Takeo MukaiVP of Fin. & Accounting and Interim CFODr. Graydon E. Beatty (Age 65)Chief Technology Officer Dr. Derrick Chou Ph.D.Chief Technology OfficerMr. Tom Sohn (Age 47)Sr. VP, Gen. Counsel & Sec. Mr. Shibaji Shome Ph.D.VP of MarketingMr. Charlie Piscitello (Age 59)Sr. VP & Chief People Officer Mr. Gary W. Doherty (Age 56)Sr. VP of Fin. More ExecutivesKey CompetitorsenVVeno MedicalNASDAQ:NVNOLucid DiagnosticsNASDAQ:LUCDPAVmedNASDAQ:PAVMIsorayNYSE:ISRSeaStar MedicalNASDAQ:ICUView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Bought 470,719 shares on 11/15/2022Ownership: 4.014%Kamunting Street Capital Management L.P.Sold 16,460 shares on 11/15/2022Ownership: 1.985%Renaissance Technologies LLCBought 141,100 shares on 11/14/2022Ownership: 1.419%R Scott HuennekensSold 60,000 sharesTotal: $34,800.00 ($0.58/share)View All Insider TransactionsView All Institutional Transactions AFIB Stock - Frequently Asked Questions Should I buy or sell Acutus Medical stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Acutus Medical in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AFIB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AFIB, but not buy additional shares or sell existing shares. View AFIB analyst ratings or view top-rated stocks. What is Acutus Medical's stock price forecast for 2023? 3 analysts have issued 1-year price targets for Acutus Medical's shares. Their AFIB share price forecasts range from $1.50 to $2.50. On average, they predict the company's share price to reach $2.00 in the next twelve months. This suggests a possible upside of 7.0% from the stock's current price. View analysts price targets for AFIB or view top-rated stocks among Wall Street analysts. How have AFIB shares performed in 2023? Acutus Medical's stock was trading at $1.15 at the start of the year. Since then, AFIB stock has increased by 62.6% and is now trading at $1.87. View the best growth stocks for 2023 here. When is Acutus Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 29th 2023. View our AFIB earnings forecast. How were Acutus Medical's earnings last quarter? Acutus Medical, Inc. (NASDAQ:AFIB) announced its quarterly earnings data on Thursday, November, 10th. The company reported ($0.72) EPS for the quarter, beating the consensus estimate of ($0.83) by $0.11. The company earned $3.64 million during the quarter, compared to analyst estimates of $3.52 million. Acutus Medical had a negative net margin of 545.51% and a negative trailing twelve-month return on equity of 100.62%. What guidance has Acutus Medical issued on next quarter's earnings? Acutus Medical updated its FY 2022 earnings guidance on Sunday, January, 29th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $16.10 million-$16.30 million, compared to the consensus revenue estimate of $15.70 million. What other stocks do shareholders of Acutus Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Acutus Medical investors own include Oak Street Health (OSH), Alibaba Group (BABA), Checkmate Pharmaceuticals (CMPI), Salesforce (CRM), Walt Disney (DIS), DocuSign (DOCU), Marvell Technology (MRVL), NVIDIA (NVDA), Tesla (TSLA) and Twilio (TWLO). When did Acutus Medical IPO? (AFIB) raised $126 million in an initial public offering (IPO) on Thursday, August 6th 2020. The company issued 7,400,000 shares at $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. What is Acutus Medical's stock symbol? Acutus Medical trades on the NASDAQ under the ticker symbol "AFIB." Who are Acutus Medical's major shareholders? Acutus Medical's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include James F Hinrichs, Orbimed Advisors Llc and R Scott Huennekens. View institutional ownership trends. How do I buy shares of Acutus Medical? Shares of AFIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Acutus Medical's stock price today? One share of AFIB stock can currently be purchased for approximately $1.87. How much money does Acutus Medical make? Acutus Medical (NASDAQ:AFIB) has a market capitalization of $53.21 million and generates $15.76 million in revenue each year. The company earns $-117,680,000.00 in net income (profit) each year or ($3.10) on an earnings per share basis. How many employees does Acutus Medical have? The company employs 291 workers across the globe. How can I contact Acutus Medical? Acutus Medical's mailing address is 2210 FARADAY AVE SUITE 100, CARLSBAD CA, 92008. The official website for the company is www.acutusmedical.com. The company can be reached via phone at 442-232-6080, via email at investors@acutusmedical.com, or via fax at 442-232-6081. This page (NASDAQ:AFIB) was last updated on 2/2/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.